TB kills more people than any other infectious disease and is the leading killer of people living with HIV; about one in three deaths among people with HIV are due to TB.
The Global Fund provides 69% of all international financing for tuberculosis (10% of total available resources) and has disbursed US$6.6 billion for TB programs and US$2.1 for TB/ HIV programs as of June 2019. As the leading international funder of TB programs, the Global Fund is a critical partner in achieving the new targets set at the UN High-Level Meeting.
See the results of these initiative and others in the fight against tuberculosis worldwide in the Global Fund’s Results Report 2019 .
GFAN Speaker Timur Abdullaev shares his insights as an HIV+ person who received lifesaving tuberculosis treatment from a Global Fund program with participants of the RESULTS International Conference. He is confident that we can...
Publisher: Friends of the Global Fight Against AIDS, Tuberculosis and Malaria
The world has made remarkable progress over the past two decades to address AIDS, tuberculosis and malaria, and increased investment can help ensure disease resurgence does not undo these gains. Stepped-up funding for the Global Fund and U.S. bilateral programs is our best defense against future disease resurgence.
The path forward is clear: to end AIDS, tuberculosis and malaria, we must scale up prevention and treatment, strengthen surveillance systems and invest in innovation. Drawing on historical examples and empirical evidence about resurgence, this new report demonstrates why it is crucial for U.S. policymakers to invest in the Global Fund.
In the era of declining development assistance for health, transitioning externally funded programs to governments becomes a priority for donors. However, the process requires a careful approach not only to preserve the public health gains that have already been achieved but also to expand on them. In the Eastern Europe and Central Asia region, countries are expected to graduate from support from the Global Fund to Fight AIDS, Tuberculosis and Malaria in or before 2025. We aim to describe transition risks and identify possible means to address them.
Publisher: Journal of the American Medical Association
In 2015, member states of the United Nations adopted the ambitious Sustainable Development Goals (SDGs), which included 17 global goals that targeted economic and social development.1 Goal 3, “to ensure healthy lives and promote well-being for all at all ages,” targets specifically marked progress in universal health coverage; improved access to safe, effective, and affordable medicines; and the end of the HIV, malaria, and tuberculosis epidemics by 2030.
This study aims to analyze different patterns and gaps of care along the care cascade across countries and to develop a model to examine the relationship between performance of tuberculosis programmes in high and low burden countries along the tuberculosis care cascade and tuberculosis disease burden.
GFAN members Friends of the Global Fund Europe and Osservatorio AiDS, together with AIDOS, and the theatre company Bluestocking, launched, last month, for World TB Day a short video highlighting the most common stereotypes on TB in Italy.
The video uses ironic messages to shape the audiences’ understanding of the portrayed clichés and highlight the critical role of the Global Fund in addressing the global reach of TB.
Many of the stereotypes portrayed in the video are common in other countries and they wanted to share a version with English subtitles of their video.
The video was initially launched in Italy on World TB Day. They have produced a similar video on HIV/AIDS which can be found below.
A similar video on Malaria will be released later this month.
The videos
are part of a joint information campaign to make the Global Fund better
known in Italy ahead of the next replen...
